Related Experiment Video
Updated: Jun 10, 2026

Improved 3D Hydrogel Cultures of Primary Glial Cells for In Vitro Modelling of Neuroinflammation
Published on: December 8, 2017
Contribution of systemic inflammation to chronic neurodegeneration
1School of Biological Sciences, University of Southampton, Southampton General Hospital, Southampton SO16 6YD, UK. vhp@soton.ac.uk
Abstract:
Systemic infection or inflammation gives rise to signals that communicate with the brain and leads to changes in metabolism and behaviour collectively known as sickness behaviour. In healthy young individuals, these changes are normally transient with no long-term consequences. The microglia are involved in the immune to brain signalling pathways. In the aged or diseased brain, the microglia have a primed phenotype as a consequence of changes in their local microenvironment. Systemic inflammation impacts on these primed microglia and switches them from a relatively benign to an aggressive phenotype with the enhanced synthesis of pro-inflammatory mediators. Recent evidence suggests that systemic inflammation contributes to the exacerbation of acute symptoms of chronic neurodegenerative disease and may accelerate disease progression. The normal homeostatic role that microglia play in signalling about systemic infections and inflammation becomes maladaptive in the aged and diseased brain and this offers a route to therapeutic intervention. Prompt treatment of systemic inflammation or blockade of signalling pathways from the periphery to the brain may help to slow neurodegeneration and improve the quality of life for individuals suffering from chronic neurodegenerative disease.
Insights
Systemic inflammation can worsen neurodegenerative diseases by activating brain immune cells called microglia. Targeting these pathways may slow disease progression and improve patient quality of life.
Area of Science:
- Neuroimmunology
- Neuroinflammation
- Brain-Body Communication
Background:
- Systemic infections and inflammation trigger sickness behavior via brain signaling.
- Microglia, the brain's immune cells, are crucial in this communication.
- In aged or diseased brains, microglia adopt a primed, more reactive state.
Purpose of the Study:
- To investigate how systemic inflammation affects primed microglia in the brain.
- To explore the role of microglia in the exacerbation of neurodegenerative diseases.
- To identify therapeutic targets for managing neuroinflammation in chronic conditions.
Main Methods:
- The study reviews recent evidence on microglia activation by systemic inflammation.
- It examines the shift from homeostatic to maladaptive microglial responses.
- Focuses on signaling pathways from the periphery to the brain.
Main Results:
- Systemic inflammation can switch primed microglia to an aggressive phenotype.
- This leads to enhanced production of pro-inflammatory mediators.
- Aggravated neuroinflammation may accelerate neurodegenerative disease progression.
Conclusions:
- The maladaptive role of microglia in aged/diseased brains presents a therapeutic target.
- Treating systemic inflammation or blocking peripheral-to-brain signaling may mitigate neurodegeneration.
- Interventions could improve quality of life for patients with chronic neurodegenerative diseases.
Related Concept Videos
Chronic Inflammation: Introduction
Inflammation
Bacterial Meningitis II: Pathophysiology
Acute Inflammation III: Local and Systemic Effects
Alzheimer Disease ll: Pathophysiology
Inflammatory Bowel Disease III: Crohn's Disease

